The Union Cycliste Internationale (UCI) announces that Chinese rider Junhong Lin has been notified of an Adverse Analytical Finding (AAF) for the presence of Anabolic Androgenic Steroids (AAS)*.
This AAF results from the reanalysis of a sample collected on 16 January 2016 at the third round of the 2016 UCI Track World Cup in Hong Kong (China).
The reanalysis occurred in the framework of the reanalysis programmer led by the International Testing Agency (ITA) on behalf of the UCI. These reanalyses constitute an integral component of the comprehensive anti-doping programme conducted independently by the ITA on behalf of the UCI since 2021. They strengthen anti-doping endeavours by serving as an additional deterrent against doping and broadening the spectrum of potential rule violations identified beyond the initial sample analysis. The reanalysis programme enables further testing to be carried out based on updated information, notably thanks to investigations, or when detection methods evolve as a result of advances in scientific technology.
Under the World Anti-Doping Code, samples may be stored for 10 years following their collection, maintaining the same legal consequence in the case of reanalysis.
In accordance with the UCI Anti-Doping Rules, the rider has been provisionally suspended. She has the right to request the analysis of the B sample.
The UCI will not comment further while the proceedings are ongoing.
* AAS are Prohibited Substances listed under class S1.1 of the Prohibited List which is maintained by the World Anti-Doping Agency and adopted by the UCI.